Management Team
Carmichael Roberts, Chairman
As a partner at North Bridge Venture Partners, Carmichael's scientific expertise has positioned the firm to capitalize on breakthroughs in chemistry and materials. Now as chairman of Dentsable, Carmichael leverages his skills as business leader, entrepreneur and technologist. Previously, Carmichael co-founded and served as the President and CEO of Arsenal Medical, a company that develops implantable medical materials. He has co-founded several other ventures, including Nano-Terra, an electronics and industrial materials company and Ancora, a carbohydrate materials company making vaccines. Prior to his entrepreneurial career, Carmichael worked in business development at GelTex Pharmaceuticals and in new product and business development at Dow Chemical. Carmichael holds a BS and PhD in organic chemistry from Duke University, completed his postdoctoral National Science Foundation fellowship at Harvard University and also holds an MBA from the MIT Sloan School of Management.
Marcus Lovell Smith, CEO
Marcus joined Dentsable from Microbia, Inc., an industrial biotechnology company developing unique microbes capable of producing high value chemicals from renewable raw materials. Marcus was CEO of Microbia and arranged its sale to DSM in 2010. Prior to Microbia, Marcus established and funded a series of start-ups in different industries, including telecommunications, the environmental sector, utilities and financial services. Many of these companies were based on creative new concepts and innovative products. Marcus received an MA from Oxford University.
|